Viking Therapeutics, Inc. short interest in 2026
In 2026, Viking Therapeutics, Inc.'s disclosed short interest ran from 22.23% of shares outstanding on 15 Jan 2026 to 19.36% on 15 Sep 2026, a change of -2.87 percentage points. The year's high was 23.06% on 30 Jan 2026 and its low 19.02% on 31 Aug 2026, averaging 20.33% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.30 days on 14 Aug 2026. Full history: Viking Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 22.23% (15 Jan 2026)
- End of year
- 19.36% (15 Sep 2026)
- Change
- -2.87 pp
- High
- 23.06% (30 Jan 2026)
- Low
- 19.02% (31 Aug 2026)
- Average
- 20.33%
- Highest days to cover
- 13.30 (14 Aug 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 22.23% | 5.97 | |
| 30 Jan 2026 | 23.06% | 9.88 | |
| 13 Feb 2026 | 22.64% | 6.93 | 10-K filed, results (8-K) |
| 27 Feb 2026 | 21.05% | 10.84 | |
| 13 Mar 2026 | 21.03% | 9.88 | |
| 31 Mar 2026 | 20.77% | 9.82 | |
| 15 Apr 2026 | 19.90% | 11.05 | |
| 30 Apr 2026 | 19.51% | 8.92 | results (8-K), 10-Q filed |
| 15 May 2026 | 19.19% | 11.20 | |
| 29 May 2026 | 19.27% | 11.69 | |
| 15 Jun 2026 | 20.08% | 11.64 | |
| 30 Jun 2026 | 20.25% | 6.65 | |
| 15 Jul 2026 | 19.85% | 9.84 | |
| 31 Jul 2026 | 19.32% | 10.49 | 10-Q filed, results (8-K) |
| 14 Aug 2026 | 19.10% | 13.30 | |
| 31 Aug 2026 | 19.02% | 12.39 | |
| 15 Sep 2026 | 19.36% | 12.32 |
See also: Viking Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.